DK3625213T3 - (+)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine fumarate, a process for its preparation and uses thereof - Google Patents

(+)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine fumarate, a process for its preparation and uses thereof Download PDF

Info

Publication number
DK3625213T3
DK3625213T3 DK18730980.2T DK18730980T DK3625213T3 DK 3625213 T3 DK3625213 T3 DK 3625213T3 DK 18730980 T DK18730980 T DK 18730980T DK 3625213 T3 DK3625213 T3 DK 3625213T3
Authority
DK
Denmark
Prior art keywords
methoxypyrrolidine
difluorophenyl
fumarate
preparation
methoxypyrrolidine fumarate
Prior art date
Application number
DK18730980.2T
Other languages
Danish (da)
English (en)
Inventor
Clas Sonesson
Maija Buksa
Inese Reine
Original Assignee
Integrative Res Laboratories Sweden Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Integrative Res Laboratories Sweden Ab filed Critical Integrative Res Laboratories Sweden Ab
Application granted granted Critical
Publication of DK3625213T3 publication Critical patent/DK3625213T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids
    • C07C57/15—Fumaric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/11—Compounds covalently bound to a solid support
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
DK18730980.2T 2017-05-19 2018-05-18 (+)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine fumarate, a process for its preparation and uses thereof DK3625213T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP17171938 2017-05-19
EP17195451 2017-10-09
EP17207406 2017-12-14
EP18151428 2018-01-12
PCT/EP2018/063123 WO2018211080A1 (en) 2017-05-19 2018-05-18 (+)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine or pharmaceutically acceptable salts thereof, a process for preparation thereof and uses thereof

Publications (1)

Publication Number Publication Date
DK3625213T3 true DK3625213T3 (da) 2023-04-24

Family

ID=62599537

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18730980.2T DK3625213T3 (da) 2017-05-19 2018-05-18 (+)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine fumarate, a process for its preparation and uses thereof

Country Status (10)

Country Link
US (3) US11078158B2 (enExample)
EP (1) EP3625213B1 (enExample)
JP (1) JP7126522B2 (enExample)
CN (1) CN110621659B (enExample)
CA (1) CA3064136A1 (enExample)
DK (1) DK3625213T3 (enExample)
ES (1) ES2943252T3 (enExample)
FI (1) FI3625213T3 (enExample)
PL (1) PL3625213T3 (enExample)
WO (1) WO2018211080A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020239568A1 (en) * 2019-05-24 2020-12-03 Integrative Research Laboratories Sweden Ab Pharmaceutically acceptable salts of [2-(3-fluoro-5-methane-sulfonylphenoxy)ethyl](propyl)amine and uses thereof
CA3180417A1 (en) * 2020-06-10 2021-12-16 Guillaume Dutheuil Synthesis of (2s,5r)-5-(2-chlorophenyl)-1-(2'-methoxy-[1,1'-biphenyl]-4-carbonyl)pyrrolidine-2-carboxylic acid
WO2025003437A1 (en) 2023-06-28 2025-01-02 Integrative Research Laboratories Sweden Ab A pharmaceutical composition comprising a fumaric acid salt of (+)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0586229A1 (en) * 1992-09-01 1994-03-09 Zeneca Limited 3-Hydroxy-3-(subst-akyl)-pyrrolidines as 5-lipoxygenase inhibitors
EP1582524B1 (en) 2004-04-02 2008-08-13 Ludwig Maximilians Universität Method of preparing organomagnesium compounds
CN101808987A (zh) * 2007-06-05 2010-08-18 Nsab神经研究瑞典公司分公司 作为皮层儿茶酚胺能神经传递调节剂的二取代的苯基吡咯烷
WO2010058018A1 (en) * 2008-11-24 2010-05-27 Nsab, Filial Af Neurosearch Sweden Ab, Sverige 3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission
CN104447490B (zh) * 2014-11-19 2017-06-06 连云港恒运医药有限公司 一种质子泵抑制剂的晶型、制备中间体及其合成方法和医药用途

Also Published As

Publication number Publication date
FI3625213T3 (fi) 2023-05-29
US12091384B2 (en) 2024-09-17
CA3064136A1 (en) 2018-11-22
ES2943252T3 (es) 2023-06-12
US20240400505A1 (en) 2024-12-05
CN110621659A (zh) 2019-12-27
JP2020520936A (ja) 2020-07-16
PL3625213T3 (pl) 2023-07-17
US20200024231A1 (en) 2020-01-23
CN110621659B (zh) 2023-02-28
JP7126522B2 (ja) 2022-08-26
EP3625213A1 (en) 2020-03-25
EP3625213B1 (en) 2023-03-08
WO2018211080A1 (en) 2018-11-22
US11078158B2 (en) 2021-08-03
US20210317081A1 (en) 2021-10-14

Similar Documents

Publication Publication Date Title
JP2017137500A5 (enExample)
HUE052796T2 (hu) Eljárás 4-ammónium-2,2,6,6-tetraalkilpiperidinil-sók elõállítására
IL275272A (en) METHOD FOR MANUFACTURING 5,5-DI-META-5,4- DIHYDROISOXAZOLE
ZA201906079B (en) Novel ester compounds, method for the production thereof and use thereof
GB2577981B (en) Methods, products & Uses relating thereto
IL272055A (en) 8,1-naphthyridinone compounds and their uses
WO2018101663A3 (ko) 생체 조직 투명화용 조성물 및 이를 이용한 생체 조직 투명화 방법
ZA201905065B (en) Novel ester compounds, method for the production thereof and use thereof
DK3463351T3 (da) Behandling til parkinsons sygdom
GB201813648D0 (en) Methods, products & uses relating thereto
DK3625213T3 (da) (+)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine fumarate, a process for its preparation and uses thereof
SI3592723T1 (sl) Postopek za pripravo 3,3,3-trifluoroprop-1-ene
EP3398943A4 (en) Method for producing 1,2,3,5,6-pentathiepane
ZA202004349B (en) Fluoralkenyl compounds, process for preparation and use thereof
GB201912016D0 (en) Methods, products & uses relating thereto
PL3105243T3 (pl) Pochodne 2',3'-dideoksy-5-fluorourydyny, sposób ich wytwarzania i zastosowanie
FI20155729A7 (fi) Menetelmä ja tuote
IL271148A (en) Process for preparing 4,3-dichloro-n-(2-cyanophenyl)-5-isothiazolecarboxamide
GB201722014D0 (en) Analgesic 2,4,6-trinitro-3,3-dimethyl-5-tert-butylbenzene production plant
GB201722269D0 (en) 1,2-benzisothiazolin-3-one production plant
GB201722196D0 (en) N, N'-nickel di-n-butyldithiocarbamate production plant
PL3153022T3 (pl) N-(3’,4’-dichloro-5-metoksybifenyl-2-ylo)-3-(difluorometylo)-1-metylo-1H-pirazolo-4-karboksyamid
GB201714439D0 (en) Organic intermediate 1,6-cyclohexanedione synthesis method
PH12016502477B1 (en) Novel polymorphic form of n-[2-(6-fluoro-lh-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluoropropoxy)benzylamine hydrochloride for the treatment of alzheimer`s
IT201700007843U1 (it) "macchina germogliatrice perfezionata".